# Pilot Trial of Oral Sodium Bicarbonate Versus Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis

> **NCT07688434** · NA · NOT_YET_RECRUITING · sponsor: **University of Sfax** · enrollment: 37 (estimated)

## Conditions studied

- End-stage Renal Disease (ESRD)
- Chronic Hemodialysis
- Metabolic Acidosis

## Interventions

- **DIETARY_SUPPLEMENT:** Oral sodium bicarbonate
- **OTHER:** Increased Dialysate Bicarbonate

## Key facts

- **NCT ID:** NCT07688434
- **Lead sponsor:** University of Sfax
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07688434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07688434, "Pilot Trial of Oral Sodium Bicarbonate Versus Higher Dialysate Bicarbonate in Hemodialysis Patients With Metabolic Acidosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07688434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*